N~2~-Benzoyl-N,N-dipropyl-alpha-glutamine(CAS: 6620-60-6)

N~2~-Benzoyl-N,N-dipropyl-alpha-glutamine (CAS: 6620-60-6) is subject to regulatory guidelines such as GHS for hazardous communication, REACH for registration, evaluation, authorization, and restriction of chemicals within the European Union, and FDA for pharmaceuticals in the United States. EPA regulations may also apply for environmental and safety standards. Compliance with these guidelines is crucial for safe handling and use.

Alternatives to N~2~-Benzoyl-N,N-dipropyl-alpha-glutamine (CAS: 6620-60-6) include similar compounds such as N~2~-Benzoyl-N,N-dipropyl-thio-glutamine and N~2~-Benzoyl-N,N-dipropyl-beta-glutamine. Isomers and analogs can also be considered. Common alternatives in synthesis include the use of other amino acids or synthetic intermediates.

The market for N~2~-Benzoyl-N,N-dipropyl-alpha-glutamine (CAS: 6620-60-6) is primarily driven by its use in pharmaceuticals and research. Recent trends include increased research in its application for treating certain neurological conditions and as a potential therapeutic agent. Market demand is expected to grow as new applications are discovered and developed.

Waste containing N~2~-Benzoyl-N,N-dipropyl-alpha-glutamine (CAS: 6620-60-6) should be collected in appropriate containers and disposed of via incineration or professional waste disposal services. Environmental protection measures include minimizing waste by recycling where possible and ensuring any waste is handled in compliance with local regulations. Proper labeling and documentation are essential for safe disposal.